Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Shield Thera (STX) Share Price

Price 7.55p on 30-03-2026 at 12:52:21
Change -0.45p -5.63%
Buy 7.60p
Sell 7.50p
Last Trade: Buy 5,511.00 at 7.60p
Day's Volume: 1,046,462
Last Close: 8.00p
Open: 8.00p
ISIN: GB00BYV81293
Day's Range 7.55p - 8.00p
52wk Range: 2.20p - 12.35p
Market Capitalisation: £80.63m
VWAP: 7.687566p
Shares in Issue: 1.07b

Shield Thera (STX) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 5,511 7.60p Ordinary
13:52:19 - 30-Mar-26
Buy* 15 7.60p SI Trade
13:52:19 - 30-Mar-26
Buy* 71 7.60p SI Trade
13:52:19 - 30-Mar-26
Buy* 5,000 7.60p SI Trade
13:52:19 - 30-Mar-26
Sell* 160,000 7.5224p Ordinary
12:54:41 - 30-Mar-26
Sell* 1,369 7.64p Ordinary
12:36:13 - 30-Mar-26
Sell* 25,000 7.635p Ordinary
12:18:19 - 30-Mar-26
Buy* 6 7.7805p Ordinary
12:12:23 - 30-Mar-26
Sell* 6,000 7.635p Ordinary
11:53:00 - 30-Mar-26
Sell* 10,000 7.65p Ordinary
10:41:34 - 30-Mar-26
See more Shield Thera trades

Shield Thera (STX) Share Price History

Time period:
to
Date Open High Low Close Volume
27th Mar 2026 (Fri) 8.20 8.00 7.80 8.00 5,832,057
26th Mar 2026 (Thu) 8.20 8.20 8.20 8.20 742,728
25th Mar 2026 (Wed) 8.05 8.30 8.05 8.20 1,693,805
24th Mar 2026 (Tue) 7.90 8.05 7.90 8.05 925,409
23rd Mar 2026 (Mon) 8.05 8.00 8.00 8.00 1,632,118
20th Mar 2026 (Fri) 7.70 8.10 7.70 8.10 1,732,237
19th Mar 2026 (Thu) 8.30 7.90 7.70 7.70 5,334,739
18th Mar 2026 (Wed) 8.25 8.30 8.24 8.30 3,426,124
17th Mar 2026 (Tue) 8.30 8.30 8.25 8.25 483,436
16th Mar 2026 (Mon) 8.30 8.30 8.25 8.30 584,902
13th Mar 2026 (Fri) 8.30 8.24 8.24 8.24 722,100
12th Mar 2026 (Thu) 8.50 8.50 8.30 8.30 420,303
11th Mar 2026 (Wed) 8.55 8.55 8.40 8.50 966,154
10th Mar 2026 (Tue) 8.35 8.55 8.30 8.55 3,509,772
9th Mar 2026 (Mon) 8.65 8.30 8.04 8.30 5,835,105
6th Mar 2026 (Fri) 8.95 9.16 8.90 8.90 2,002,387
5th Mar 2026 (Thu) 9.10 9.04 9.04 9.04 2,195,193
4th Mar 2026 (Wed) 9.35 9.04 9.04 9.04 1,284,896
3rd Mar 2026 (Tue) 9.85 9.85 9.35 9.35 1,586,828
2nd Mar 2026 (Mon) 10.00 9.75 9.25 9.75 2,533,173
See more Shield Thera price history

Shield Thera (STX) Regulatory News

Date Source Headline
3rd Mar 2026 7:00 am RNS Chinese NMPA Accepts MAA Submission for ACCRUFeR®
27th Feb 2026 7:00 am RNS Total Voting Rights
9th Feb 2026 7:00 am RNS FDA Grants additional Exclusivity for ACCRUFeR
30th Jan 2026 7:05 am RNS Total Voting Rights
30th Jan 2026 7:00 am RNS Approval for ACCRUFeR in China expected in Q1 2026
21st Jan 2026 7:00 am RNS Q4 2025 Trading Update
2nd Jan 2026 11:06 am RNS Block listing 6 Monthly Return
2nd Jan 2026 7:00 am RNS Total Voting Rights
2nd Jan 2026 7:00 am RNS Total Voting Rights
22nd Dec 2025 7:00 am RNS FDA approves extension for ACCRUFeR®
See more Shield Thera regulatory news

Shield Thera (STX) Share News

IN BRIEF: Shield Therapeutics gets three more years of US exclusivity

9th Feb 2026 11:20

Shield Therapeutics PLC - Newcastle, England-based commercial-stage pharmaceutical company - Says the US Food & Drug Administration grants an additional three years of data exclusivity for Accrufer. The exclusivity remains in place until December 19, 2028, in addition to the Accrufer/Feraccru patent coverage valid until the mid-2030s. Read More

EARNINGS AND TRADING: Peel Hunt upbeat; Transense cuts profit outlook

30th Jan 2026 16:12

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

Shield Therapeutics reaches cash flow positivity as revenue grows

21st Jan 2026 16:24

(Alliance News) - Shield Therapeutics PLC on Wednesday said it achieved operating cash flow positivity in the fourth quarter of 2025, as it guided an operating profit in 2026. Read More

EARNINGS AND TRADING: Corel loss widens; Christie sells Vennersys

22nd Dec 2025 15:38

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

Shield Therapeutics upbeat as Accrufer trial initiated in Japan

14th Nov 2025 12:08

(Alliance News) - Shield Therapeutics PLC on Friday reported the commencement of a phase two Accrufer trial in Japan for the treatment of pulmonary arterial hypertension. Read More

See more Shield Thera news
FTSE 100 Latest
Value10,074.54
Change107.19

Login to your account

Forgot Password?

Not Registered